HeartBeam president granted options on 61,932 shares

HeartBeam, Inc. reported that President and director Branislav Vajdic received a grant of options to buy 61,932 shares of common stock at an exercise price of $1.45 per share.

Rhea-AI Filing Summary

HeartBeam, Inc. reported that President and director Branislav Vajdic received a grant of options to buy 61,932 shares of common stock at an exercise price of $1.45 per share. The options were granted on February 9, 2026 and expire on January 1, 2036.

According to the vesting terms, one half of the shares subject to this special option will vest on March 31, 2026, with the remaining shares vesting on June 30, 2026, based on a vesting commencement date of January 1, 2026. After this grant, Vajdic holds options for 61,932 underlying shares under the company’s 2022 Equity Incentive Plan.

Insider Trade Summary

Grant/Award: 61,932 shares

Grant/Award 1 txn

Insider Vajdic Branislav

Role President

Type	Security	Shares	Price	Value
Grant/Award	Common Stock (right to buy)	61,932	$0.00	$0.00

Holdings After Transaction: Common Stock (right to buy) — 61,932 contracts (Direct)

Footnotes (1)

1. F1. Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did HeartBeam (BEAT) President Branislav Vajdic report on this Form 4?

Branislav Vajdic reported receiving stock options for 61,932 HeartBeam common shares. These options were granted as a compensation award, allowing him to buy shares at a fixed exercise price under the company’s 2022 Equity Incentive Plan, subject to a short-term vesting schedule.

How many HeartBeam (BEAT) shares are covered by the new option grant?

The option grant covers 61,932 underlying shares of HeartBeam common stock. All 61,932 shares are tied to a single “Special Option” award, providing the President with the right to purchase those shares if and when the options vest and are exercised.

What is the exercise price of Branislav Vajdic’s HeartBeam (BEAT) options?

The options have an exercise price of $1.45 per share. This means Vajdic can buy up to 61,932 HeartBeam common shares at $1.45 each once the options vest, regardless of the market price at that future time.

When do the newly granted HeartBeam (BEAT) options vest for the President?

Half of the option shares vest on March 31, 2026, and the remaining half vest on June 30, 2026. The vesting schedule is based on a vesting commencement date of January 1, 2026, giving a rapid, six-month full vesting period.

When do Branislav Vajdic’s HeartBeam (BEAT) options expire?

The options expire on January 1, 2036. If they are not exercised by that date, the right to purchase the 61,932 underlying HeartBeam shares at $1.45 per share will lapse, and the options will no longer be usable.

Are the HeartBeam (BEAT) options granted to Vajdic part of a company equity plan?

Yes, the options were issued under HeartBeam’s 2022 Equity Incentive Plan. This plan is used to grant stock-based compensation to executives and other participants, aligning their potential rewards with the company’s long-term performance through equity-linked awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/23/2026 - 05:36 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vajdic Branislav

(Last) (First) (Middle)

2118 WALSH AVENUE, SUITE 210

15TH FL

(Street)

SANTA CLARA CALIFORNIA 95050

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HeartBeam, Inc. [ BEAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock (right to buy)	$1.45	02/09/2026		A		61,932		(1)	01/01/2036	Common Stock	61,932	$0	61,932	D

Explanation of Responses:

1. Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.

	/s/ Branislav Vajdic	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)